Tousled-like kinases stabilize replication forks and show synthetic lethality with checkpoint and PARP inhibitors

Sung-Bau Lee1,2, Sandra Segura-Bayona3, Marina Villamor-Payà3

  • 1Biotech Research and Innovation Centre (BRIC), Faculty of Health Sciences, University of Copenhagen, 2200 Copenhagen, Denmark.

Science Advances
|August 14, 2018
PubMed

Insights

Tousled-like kinases (TLKs) are crucial for DNA replication and chromatin assembly. Inhibiting TLKs causes replication stress and DNA damage, offering potential cancer treatment strategies by targeting cancer cells with upregulated TLK genes.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Biology

Background:

  • Faithful duplication and transmission of DNA sequence and epigenetic information during cell division is essential.
  • The integration of chromatin assembly and DNA replication processes remains incompletely understood.

Purpose of the Study:

  • To investigate the role of Tousled-like kinases 1 and 2 (TLK1/TLK2) in chromatin assembly.
  • To determine the contribution of TLK1/TLK2 to the maintenance of replication fork integrity.

Main Methods:

  • Examined the effects of TLK activity depletion on DNA replication and nucleosome assembly.
  • Assessed replication fork stability, DNA damage accumulation, and cell cycle progression.
  • Analyzed human cancer data for TLK gene expression and patient outcomes.

Main Results:

  • TLK activity is essential for DNA replication and replication-coupled nucleosome assembly.
  • TLK depletion causes replication fork stalling, single-stranded DNA accumulation, and replication-dependent DNA damage.
  • Deficient nucleosome assembly leads to replication fork instability, dependent on ATR, CHK1, and PARP for survival.

Conclusions:

  • TLKs play a critical role in chromatin replication and suppressing replication stress.
  • Upregulation of TLK genes in human cancers correlates with poor patient outcomes.
  • Targeting TLKs presents a potential therapeutic strategy, especially in combination with checkpoint signaling and PARP inhibitors.